Just a month out from being bought by French giant bioMérieux, BioFire Diagnostics took its FilmArray diagnostic system's new gastrointestinal option to the FDA for clearance, which the newly united ...

BioFire Diagnostics won 510(k) clearance for its gastrointestinal panel for infectious diarrhea, following in the footsteps of the company's acquisition by French diagnostic giant bioMérieux.

胃肠病原体检测的Hologic Panther Fusion GI检测方法与Verigene EP、BioFire GI的对比研究表明，三者在主要病原体（如沙门氏菌、弯曲杆菌）检测中PPA和NPA均超过95%，但Fusion GI在Yersinia enterocolitica检测中PPA为72.2%，部分假阴性可能与冻存样本核酸降解有关。 在当今医疗诊断 ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, ...

SALT LAKE CITY, Utah (March 26, 2013) — BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next ...